Compare BridgeBio Pharma Inc (BBIO) vs Hewlett Packard Enterprise Co (HPE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Hewlett Packard Enterprise Co — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.61B), while Hewlett Packard Enterprise Co trades at $55.39 (market cap $72.41B). The key difference: Hewlett Packard Enterprise Co is far larger — about 4.4× BridgeBio Pharma Inc's market cap, and Hewlett Packard Enterprise Co pays a 1.04% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | HPE | |
|---|---|---|
Market Cap | $16.61B | $72.41B |
Sector | Health | Technology |
52-Week High | $90.17 | $56.14 |
52-Week Low | $47.29 | $20.01 |
Enterprise Value | $18.16B | $88.36B |
Dividend Yield | — | 1.04% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Hewlett Packard Enterprise Co
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment.
Read more on HPE →
